Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a 12.130% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: COc1ccc(CCC(=O)NCCc2ccc(Cl)cc2)cc1
b: O=C(c1cc2ccccc2oc1=O)N(Cc1ccccc1)CC1CCCO1
c: O=C(NCc1ccccc1)C1CCN(S(=O)(=O)c2cccc3nonc23)CC1
d: CN1CCN(Cc2c(O)ccc3cc(-c4ccccn4)c(=O)oc23)CC1
Answer: d. CN1CCN(Cc2c(O)ccc3cc(-c4ccccn4)c(=O)oc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(Cc2c(O)ccc3cc(-c4ccccn4)c(=O)oc23)CC1
CN1CCN(Cc2c(O)ccc3cc(-c4ccccn4)c(=O)oc23)CC1
7-hydroxy-8-[(4-methylpiperazin-1-yl)methyl]-3-pyridin-2-ylchromen-2-one